ArticleInvestigational new drugs2024

Efficacy of immune checkpoint inhibitor rechallenge in initial immunotherapy responders with advanced non-small cell lung cancer: A single-center retrospective study.

Manyi Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.